Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial

Ligang Xing, Gang Wu, Lühua Wang, Jiancheng Li, Jianhua Wang, Zhiyong Yuan, Ming Chen, Yaping Xu, Xiaolong Fu, Zhengfei Zhu, You Lü, Chun Han, Tingyi Xia, Conghua Xie, Guang Li, Shenglin Ma, Bing Lü, Qin Lin, Guangying Zhu, Baolin Qu, Wanqi Zhu, Jinming Yu